Perinatal Pitocin as an early ADHD biomarker: neurodevelopmental risk?
1Department of Psychology, Colorado State University, c/o Alpine Behavior Therapy Clinic, 1918 South Lemay, Suite B, Fort Collins, CO 80525, USA. Lisa.Kurth@ColoState.edu
Insights
Perinatal Pitocin exposure may increase the risk of childhood Attention Deficit Hyperactivity Disorder (ADHD). This study found a significant association between Pitocin use during childbirth and later ADHD diagnosis in children.
Area of Science:
- Neurodevelopmental Disorders
- Obstetrics
- Pediatric Neurology
Background:
- Attention Deficit Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder.
- Identifying early risk factors for ADHD is crucial for timely intervention.
- Perinatal factors, including obstetric interventions, are being investigated for their potential role in ADHD etiology.
Purpose of the Study:
- To explore a potential association between the use of Pitocin during labor and delivery and the subsequent development of ADHD in children.
- To identify perinatal Pitocin exposure as a potential early biomarker for ADHD.
Main Methods:
- A retrospective analysis of maternal labor/delivery and childbirth records for 172 children aged 3-25.
- Examined 21 potential predictors of ADHD, including obstetric complications, family history, and gender.
- Group comparisons were based on ADHD diagnosis and history of perinatal Pitocin exposure.
Main Results:
- A significant predictive relationship was found between perinatal Pitocin exposure and childhood ADHD onset (67.1% vs. 35.6%, p<.001).
- Fetal exposure time, gestation length, and labor length also showed predictive value, though less pronounced than Pitocin exposure.
- The study identified a strong correlation between Pitocin use and increased likelihood of ADHD diagnosis.
Conclusions:
- The findings suggest a potential link between perinatal Pitocin exposure and ADHD diagnosis.
- Further research is warranted to confirm and understand the mechanisms behind this association.
- Perinatal Pitocin use may represent a modifiable risk factor or early indicator for ADHD.
Objective:
To investigate a potential relationship between coincidental increases in perinatal Pitocin usage and subsequent childhood ADHD onset in an attempt to isolate a specific risk factor as an early biomarker of this neurodevelopmental disorder.
Method:
Maternal labor/delivery and corresponding childbirth records of 172 regionally diverse, heterogeneous children, ages 3 to 25, were examined with respect to 21 potential predictors of later ADHD onset, including 17 selected obstetric complications, familial ADHD incidence, and gender. ADHD diagnosis and history of perinatal Pitocin exposure distinguished groups for comparison.
Results:
Results revealed a strong predictive relationship between perinatal Pitocin exposure and subsequent childhood ADHD onset (occurring in 67.1% of perinatal Pitocin cases vs. 35.6% in nonexposure cases, χ(2)=16.99, p<.001). Fetal exposure time, gestation length, and labor length also demonstrated predictive power, albeit significantly lower.
Conclusion:
The findings warrant further investigation into the potential link between perinatal Pitocin exposure and subsequent ADHD diagnosis.
More Related Videos
19:15Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
05:44Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1
Published on: May 17, 2024
